Hemex
Venture Capital
Active
Liestal, Switzerland
15
3M
9
1.67
3
0.40
- Stages of investment
- Areas of investment
Summary
Hemex is the famous Corporate Investor, which was founded in 2011. The venture was found in Europe in Switzerland. The leading representative office of defined Corporate Investor is situated in the Liestal.
The current fund was established by Pascal Winnen, Paul Hadvu00e1ry.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Hemex, startups are often financed by Venture Kick, MassChallenge Switzerland, OCCIDENT. The meaningful sponsors for the fund in investment in the same round are OCCIDENT, Zu00fcrcher Kantonalbank ZKB, Zu00fcrcher Kantonal Bank. In the next rounds fund is usually obtained by Zu00fcrcher Kantonal Bank, TRUMPF Venture, OCCIDENT.
Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Scailyte AG. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland.
The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 3
- Rounds per year
- 1.67
- Follow on index
- 0.40
- Investments by industry
- Biotechnology (9)
- Medical (7)
- Health Care (7)
- Medical Device (6)
- Life Science (5) Show 7 more
- Investments by region
-
- Switzerland (14)
- Sweden (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| hemotune | 25 Mar 2024 | Biotechnology, Health Care, Medical Device, Life Science, Therapeutics | Early Stage Venture | 15M | Switzerland, Zurich, Zurich |
| Jiff | 23 Sep 2014 | Mobile, Health Care, Medical | Early Stage Venture | 18M | United States, California, Mountain View |
| Resistell AG | 09 Dec 2018 | Medical Device | Seed | 817K | Switzerland, Basel-City, Basel |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.